Metropolitan Life Insurance CO Applied Molecular Transport Inc. Transaction History

Metropolitan Life Insurance CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$5.63 - $13.88 $37,073 - $91,399	-6,585 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$13.23 - $26.05 $87,119 - $171,539	6,585 New	6,585 $92,000
Q3 2021 Jun 21, 2023	BUY	$25.87 - $46.61 $170,353 - $306,926	6,585 New	6,585 $170,000
Q2 2021 Jun 21, 2023	BUY	$39.76 - $64.31 $261,819 - $423,481	6,585 New	6,585 $301,000
Q2 2021 Mar 30, 2023	BUY	$39.76 - $64.31 $12,723 - $20,579	320 Added 5.11%	6,585 $301,000

Q2 2021 Aug 16, 2021	BUY	$39.76 - $64.31 $261,581 - $423,095	6,579 Added 109650.0%	6,585 $301,000
Q1 2021 Jun 26, 2023	BUY	$30.5 - $74.14 $191,082 - $464,487	6,265 New	6,265 $276 Million
Q1 2021 Mar 30, 2023	BUY	$30.5 - $74.14 $73,535 - $178,751	2,411 Added 62.56%	6,265 $275,000
Q1 2021 May 14, 2021	SELL	$30.5 - $74.14 $117,364 - $285,290	-3,848 Reduced 99.84%	6 $276,000
Q4 2020 Jun 22, 2023	BUY	$29.39 - $35.0 $113,269 - $134,890	3,854 New	3,854 $118,000
Q3 2020 Jun 26, 2023	BUY	$20.49 - $33.58 $78,968 - $129,417	3,854 New	3,854 $122,000
Q3 2020 Mar 30, 2023	BUY	$20.49 - $33.58 $78,968 - $129,417	3,854 New	3,854 $122,000
Q3 2020 Nov 13, 2020	BUY	$20.49 - $33.58 $78,968 - $129,417	3,854 New	3,854 $123,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.